These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8462410)

  • 81. Differences between dropouts and active participants in a pediatric clinic for substance abuse mothers.
    Chan LS; Wingert WA; Wachsman L; Schuetz S; Rogers C
    Am J Drug Alcohol Abuse; 1986; 12(1-2):89-99. PubMed ID: 3788902
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of case management on retention in prenatal substance abuse treatment.
    Laken MP; Ager JW
    Am J Drug Alcohol Abuse; 1996 Aug; 22(3):439-48. PubMed ID: 8841690
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment.
    Eisen M; Keyser-Smith J; Dampeer J; Sambrano S
    Addict Behav; 2000; 25(1):123-9. PubMed ID: 10708327
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Government's Involvement in Prenatal Drug Testing May Be Toxic.
    Nguemeni Tiako MJ; Sweeney L
    Matern Child Health J; 2022 Apr; 26(4):761-763. PubMed ID: 33392931
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ethical, legal and policy issues in management of fetal alcohol spectrum disorder.
    Hackler C
    J Ark Med Soc; 2011 Nov; 108(6):123-4. PubMed ID: 23252025
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of social supports on attitudes, health behaviors and obtaining prenatal care.
    Giblin PT; Poland ML; Ager JW
    J Community Health; 1990 Dec; 15(6):357-68. PubMed ID: 2280035
    [TBL] [Abstract][Full Text] [Related]  

  • 87.
    Thomas KA; Struble CA; Stenersen MR; Moore K
    J Law Med Ethics; 2024; 52(S1):75-80. PubMed ID: 38995261
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The unofficial history of drug use: a study in a Brazilian sample.
    Galduróz JC; Masur J
    Br J Addict; 1990 Dec; 85(12):1577-81. PubMed ID: 2289057
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Commentary: mal-intentioned illiteracy, willful ignorance, and fetal protection laws: is there a lexicologist in the house?
    Marshall MF
    J Law Med Ethics; 1999; 27(4):343-6, 294. PubMed ID: 11067616
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Preemployment drug screening may violate the ADA.
    Rothstein MA
    J Occup Med; 1993 Jun; 35(6):554. PubMed ID: 8123081
    [No Abstract]   [Full Text] [Related]  

  • 91. Attitude toward recovery and completion of a substance abuse treatment program.
    Britt GC; Knisely JS; Dawson KS; Schnoll SH
    J Subst Abuse Treat; 1995; 12(5):349-53. PubMed ID: 8583518
    [TBL] [Abstract][Full Text] [Related]  

  • 92. On the Ethics of Mandatory Reporting of Positive Drug Tests in Newborns and Pregnant Parents at the Time of Delivery.
    Spiegel J; Cohan G; Brousseau EC; Tobin-Tyler E
    R I Med J (2013); 2022 Apr; 105(3):28-32. PubMed ID: 35349617
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Influence of job characteristics on the acceptability of employee drug testing.
    Murphy KR; Thornton GC; Prue K
    J Appl Psychol; 1991 Jun; 76(3):447-53. PubMed ID: 1864814
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Gamma hydroxybutyric acid and other party drugs. Knock-out drug risk!].
    Klein F
    MMW Fortschr Med; 2008 Oct; 150(41):17. PubMed ID: 19009835
    [No Abstract]   [Full Text] [Related]  

  • 95. Substance use and misuse in childhood and adolescence.
    Farrell M; Strang J
    J Child Psychol Psychiatry; 1991 Jan; 32(1):109-28. PubMed ID: 2037642
    [No Abstract]   [Full Text] [Related]  

  • 96. Human Behavioral Pharmacology Laboratory. University of Vermont.
    Hughes JR; Higgins ST; Bickel WK
    Br J Addict; 1990 Apr; 85(4):441-5. PubMed ID: 2346785
    [No Abstract]   [Full Text] [Related]  

  • 97. Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012.
    Landis RK; Stein BD; Griffin BA; Saloner BK; Terplan M; Faherty LJ
    J Addict Med; 2023 Nov-Dec 01; 17(6):654-661. PubMed ID: 37934525
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Polysubstance Use in Pregnancy: Surveillance, Interventions, and Next Steps.
    Park Y; Dang EP; Board A; Gilboa SM; Ondersma SJ; Smid MC; Shakib JH; Mitchell KT; England LJ; Broussard CS; Meaney-Delman D; Iskander J; Kim SY
    J Womens Health (Larchmt); 2023 Sep; 32(9):899-904. PubMed ID: 37552850
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls.
    Mazel S; Alexander K; Cioffi C; Terplan M
    Subst Abuse Rehabil; 2023; 14():49-59. PubMed ID: 37424702
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Addressing stigma within the dissemination of research products to improve quality of care for pregnant and parenting people affected by substance use disorder.
    Lipsett M; Wyant-Stein K; Mendes S; Berger E; Berkman ET; Terplan M; Cioffi CC
    Front Psychiatry; 2023; 14():1199661. PubMed ID: 37351006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.